https://investors.invivyd.com/ 2026-04-01T16:10:03-04:00 daily 1.0 https://investors.invivyd.com/committee-details/audit-committee 2025-03-30T21:46:16-04:00 0.5 https://investors.invivyd.com/committee-details/compensation-committee 2025-09-24T16:08:57-04:00 0.5 https://investors.invivyd.com/committee-details/nominating-and-corporate-governance-committee 2024-05-22T01:44:50-04:00 0.5 https://investors.invivyd.com/events/event-details/infectious-disease-society-americas-idweek-2021 2021-09-30T09:56:36-04:00 0.5 https://investors.invivyd.com/events/event-details/isirv-who-conference-2021 2021-10-19T16:51:45-04:00 0.5 https://investors.invivyd.com/events/event-details/adagio-therapeutics-inc-40th-annual-jp-morgan-healthcare-conference 2022-03-23T16:51:43-04:00 0.5 https://investors.invivyd.com/events/event-details/adagio-therapeutics-inc-2022-annual-meeting-stockholders 2022-03-21T09:46:18-04:00 0.5 https://investors.invivyd.com/events/event-details/asm-microbe-2022 2022-06-13T12:27:13-04:00 0.5 https://investors.invivyd.com/events/event-details/eccmid-2022 2022-06-16T13:58:56-04:00 0.5 https://investors.invivyd.com/events/event-details/hc-wainwright-24th-annual-global-investment-conference 2022-09-08T16:54:51-04:00 0.5 https://investors.invivyd.com/events/event-details/morgan-stanley-20th-annual-global-healthcare-conference 2022-09-08T16:55:25-04:00 0.5 https://investors.invivyd.com/events/event-details/q3-2022-invivyd-earnings-conference-call 2022-11-02T07:37:28-04:00 0.5 https://investors.invivyd.com/events/event-details/jefferies-london-healthcare-conference 2022-11-11T18:04:25-05:00 0.5 https://investors.invivyd.com/events/event-details/jp-morgan-41st-annual-healthcare-conference 2023-01-09T12:44:56-05:00 0.5 https://investors.invivyd.com/events/event-details/q4-2022-invivyd-earnings-conference-call 2023-03-16T08:35:23-04:00 0.5 https://investors.invivyd.com/events/event-details/cowens-43rd-annual-healthcare-conference 2023-05-02T07:34:06-04:00 0.5 https://investors.invivyd.com/events/event-details/hc-wainwrights-bioconnect-investor-conference 2023-04-25T16:32:34-04:00 0.5 https://investors.invivyd.com/events/event-details/q1-2023-invivyd-earnings-conference-call 2023-05-04T16:04:28-04:00 0.5 https://investors.invivyd.com/events/event-details/jefferies-healthcare-conference 2023-06-09T12:29:40-04:00 0.5 https://investors.invivyd.com/events/event-details/q2-2023-invivyd-earnings-conference-call 2023-08-31T07:13:20-04:00 0.5 https://investors.invivyd.com/events/event-details/hc-wainwright-25th-annual-global-investment-conference 2023-09-06T08:00:32-04:00 0.5 https://investors.invivyd.com/events/event-details/morgan-stanley-21st-annual-global-healthcare-conference 2023-09-06T08:00:31-04:00 0.5 https://investors.invivyd.com/events/event-details/q3-2023-invivyd-earnings-conference-call 2023-11-09T16:04:28-05:00 0.5 https://investors.invivyd.com/events/event-details/guggenheim-5th-annual-inflammation-neurology-immunology-ini-conference 2023-10-31T16:03:39-04:00 0.5 https://investors.invivyd.com/events/event-details/evercore-isi-6th-annual-healthconx-conference 2023-10-31T16:03:27-04:00 0.5 https://investors.invivyd.com/events/event-details/guggenheim-healthcare-talks-6th-annual-biotechnology-conference 2024-02-05T16:08:05-05:00 0.5 https://investors.invivyd.com/events/event-details/invivyd-eua-conference-call 2024-03-22T15:08:01-04:00 0.5 https://investors.invivyd.com/events/event-details/pemgarda-launch-update-conference-call 2024-04-04T16:02:47-04:00 0.5 https://investors.invivyd.com/events/event-details/q1-2024-invivyd-earnings-conference-call 2024-05-09T15:34:10-04:00 0.5 https://investors.invivyd.com/events/event-details/hc-wainwright-2nd-annual-bioconnect-investor-conference 2024-05-13T16:02:48-04:00 0.5 https://investors.invivyd.com/events/event-details/jefferies-global-healthcare-conference 2024-06-03T16:03:00-04:00 0.5 https://investors.invivyd.com/events/event-details/q2-2024-invivyd-earnings-conference-call 2024-08-12T16:05:43-04:00 0.5 https://investors.invivyd.com/events/event-details/invivyd-canopy-data-update-conference-call 2024-08-27T07:43:51-04:00 0.5 https://investors.invivyd.com/events/event-details/morgan-stanley-22nd-annual-global-healthcare-conference 2024-09-05T07:02:47-04:00 0.5 https://investors.invivyd.com/events/event-details/hc-wainwright-26th-annual-global-investment-conference 2024-09-05T07:02:53-04:00 0.5 https://investors.invivyd.com/events/event-details/2024-cantor-global-healthcare-conference 2024-09-05T07:02:55-04:00 0.5 https://investors.invivyd.com/events/event-details/q3-2024-invivyd-earnings-conference-call 2024-11-06T07:21:25-05:00 0.5 https://investors.invivyd.com/events/event-details/guggenheim-securities-healthcare-innovation-conference 2024-11-13T11:01:53-05:00 0.5 https://investors.invivyd.com/events/event-details/presentation-oppenheimer-35th-annual-life-sciences-conference 2025-02-10T07:01:38-05:00 0.5 https://investors.invivyd.com/events/event-details/q1-2025-invivyd-earnings-conference-call 2025-05-14T23:21:55-04:00 0.5 https://investors.invivyd.com/events/event-details/hc-wainwright-3rd-annual-bioconnect-investor-conference 2025-05-19T12:30:19-04:00 0.5 https://investors.invivyd.com/events/event-details/cantor-global-healthcare-conference-2025 2025-09-02T12:43:27-04:00 0.5 https://investors.invivyd.com/events/event-details/hc-wainwright-27th-annual-global-investment-conference 2025-09-03T08:59:27-04:00 0.5 https://investors.invivyd.com/events/event-details/invivyd-revolution-pivotal-program-conference-call 2025-10-29T21:41:06-04:00 0.5 https://investors.invivyd.com/events/event-details/q3-2025-invivyd-earnings-conference-call 2025-11-05T21:54:30-05:00 0.5 https://investors.invivyd.com/events/event-details/8th-annual-evercore-healthcare-conference 2025-12-01T16:16:18-05:00 0.5 https://investors.invivyd.com/events/event-details/q4-2025-invivyd-earnings-conference-call 2026-03-05T01:02:12-05:00 0.5 https://investors.invivyd.com/investor-overview 2026-04-01T16:10:03-04:00 0.8 https://investors.invivyd.com/news-events/press-releases 2025-09-08T09:57:26-04:00 0.8 https://investors.invivyd.com/news-events/events-presentations 2024-11-14T15:29:14-05:00 0.8 https://investors.invivyd.com/corporate-governance/documents-charters 2022-09-06T09:25:52-04:00 0.8 https://investors.invivyd.com/corporate-governance/committee-composition 2021-08-02T14:46:05-04:00 0.8 https://investors.invivyd.com/analyst-coverage 2023-08-17T06:20:16-04:00 0.8 https://investors.invivyd.com/stock-information/stock-quote-chart 2023-08-29T03:24:50-04:00 0.8 https://investors.invivyd.com/resources/investor-faqs 2023-08-17T06:21:08-04:00 0.8 https://investors.invivyd.com/resources/email-alerts 2023-08-17T06:20:45-04:00 0.8 https://investors.invivyd.com/resources/rss 2023-08-17T06:21:34-04:00 0.8 https://investors.invivyd.com/resources/contact-ir 2023-08-17T06:20:32-04:00 0.8 https://investors.invivyd.com/financial-information/sec-filings 2023-08-29T06:27:07-04:00 0.8 https://investors.invivyd.com/invivyd-news 2025-09-17T16:59:32-04:00 0.8 https://investors.invivyd.com/news-releases/news-release-details/adagio-therapeutics-announces-adg20-phase-1-data-and-initiation 2021-07-06T11:48:47-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/adagio-therapeutics-announces-336-million-series-c-financing 2021-07-06T13:01:08-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/adagio-therapeutics-initiates-global-clinical-trial-adg20 2021-07-06T13:27:53-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/adagio-therapeutics-launches-50m-series-financing-advance 2021-08-03T09:28:51-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/adagio-therapeutics-announces-appointment-howard-mayer-md-its 2021-08-03T09:32:10-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/adagio-therapeutics-strengthens-management-team-appointments 2021-08-03T09:34:44-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/adagio-therapeutics-raises-80m-series-b-round-further-advance 2021-08-03T09:38:11-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/adagio-therapeutics-covid-19-antibody-demonstrates-best-class 2021-08-03T09:42:28-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/adagio-therapeutics-publishes-preclinical-data-science 2021-08-03T09:46:03-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/adagio-therapeutics-announces-dosing-first-patient-phase-1-trial 2021-08-03T09:49:40-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/adagio-therapeutics-participate-cowen-41st-annual-health-care 2021-08-03T09:55:06-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/adagio-therapeutics-appoints-david-hering-global-covid-19 2021-08-03T09:58:09-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/adagio-therapeutics-partners-biocon-biologics-bring-potent-and 2021-08-03T10:00:40-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/adagio-therapeutics-appoints-leading-pharmaceutical-and 2021-08-03T10:03:44-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/adagio-therapeutics-announces-pricing-initial-public-offering 2021-08-06T08:13:47-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/adagio-therapeutics-announces-closing-initial-public-offering 2021-08-10T16:23:51-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/adagio-therapeutics-participate-morgan-stanley-19th-annual 2021-09-01T06:30:15-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/adagio-therapeutics-announces-expansion-patient-population 2021-09-10T06:31:00-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/adagio-therapeutics-provides-covid-19-antibody-program-updates 2021-09-20T06:31:02-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/adagio-therapeutics-announces-new-data-highlighting-potential 2021-09-29T06:30:39-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/adagio-therapeutics-participate-guggenheim-2nd-annual-vaccines 2021-09-29T06:38:48-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/adagio-therapeutics-announces-new-vitro-data-highlighting-broad 2021-10-19T06:30:11-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/adagio-therapeutics-participate-upcoming-investor-conferences 2021-11-10T06:30:20-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/adagio-therapeutics-provides-update-adg20-covid-19-antibody 2021-11-15T06:30:19-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/adagio-therapeutics-announces-expansion-management-team-and 2021-11-22T06:30:56-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/adagio-therapeutics-reports-none-mutations-present-sars-cov-2 2021-11-29T06:30:33-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/adagio-therapeutics-reports-reduction-vitro-neutralizing 2021-12-14T07:01:18-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/adagio-therapeutics-present-40th-annual-jp-morgan-healthcare 2022-01-06T06:30:44-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/adagio-therapeutics-summarizes-adg20-neutralizing-activity 2022-01-12T16:57:29-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/adagio-therapeutics-announces-ceo-succession-plan 2022-02-18T19:34:48-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/adagio-therapeutics-announces-adg20-development-plans-and 2022-02-22T07:30:53-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/adagio-therapeutics-announces-david-hering-appointed-interim 2022-02-23T16:30:50-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/adagio-therapeutics-inc-announces-2022-annual-meeting 2022-03-18T18:34:56-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/adagio-therapeutics-announces-adg20-adintrevimab-first 2022-03-30T07:26:38-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/adagio-therapeutics-provides-update-timing-adintrevimab-eua 2022-04-14T07:45:11-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/adagio-therapeutics-reports-first-quarter-2022-financial-results 2022-05-13T06:30:38-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/adagio-announces-results-annual-meeting-stockholders-and 2022-07-01T06:30:33-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/adagio-announces-david-hering-named-permanent-chief-executive 2022-07-05T07:26:31-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/adagio-therapeutics-reports-second-quarter-2022-financial 2022-08-15T06:30:40-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/adagio-therapeutics-participate-upcoming-investor-conferences-0 2022-09-06T16:02:00-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/adagio-therapeutics-announces-corporate-name-change-invivyd 2022-09-12T07:00:34-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-announces-multiple-next-generation-covid-19-antibody 2022-09-12T07:19:54-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-present-multiple-posters-highlighting-clinical-data 2022-10-12T16:01:36-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-appoints-fred-driscoll-interim-chief-financial-officer 2022-10-13T16:01:36-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-announces-appointment-christine-lindenboom-board 2022-10-24T16:01:36-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-host-conference-call-november-10-discuss-third-quarter 2022-11-02T07:00:51-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-participate-fireside-chat-jefferies-london-healthcare 2022-11-09T07:00:27-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-reports-third-quarter-2022-financial-results-and 2022-11-10T16:02:03-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-announces-partnership-population-health-partners 2022-11-17T07:00:24-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-appoints-jeremy-gowler-chief-operating-and-commercial 2022-12-06T16:01:20-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-presented-joint-industry-rationale-potential-expedited 2022-12-19T07:00:32-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-announces-changes-executive-team 2023-02-03T07:30:33-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-participate-cowens-43rd-annual-healthcare-conference 2023-02-28T07:00:22-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-optimizes-development-efficiency-election-vyd222-near 2023-03-06T07:01:08-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-host-conference-call-discussing-full-year-2022-financial 2023-03-16T07:00:34-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-publishes-model-evaluating-biomarker-correlates 2023-03-22T16:30:35-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-reports-full-year-2022-financial-results-and-business 2023-03-23T16:02:03-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-doses-first-participants-phase-1-trial-vyd222-novel 2023-03-30T16:01:43-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-appoints-robert-allen-chief-scientific-officer-and-stacy 2023-04-12T07:00:56-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-announces-fda-has-cleared-its-ind-application-vyd222 2023-04-25T07:01:14-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-participate-hc-wainwrights-bioconnect-investor 2023-04-25T16:01:40-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-host-conference-call-discussing-first-quarter-2023 2023-05-04T16:01:17-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-reports-first-quarter-2023-financial-results-and 2023-05-11T16:01:35-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-participate-jefferies-healthcare-conference 2023-06-01T07:00:22-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-announces-positive-initial-data-ongoing-phase-1-clinical 2023-06-22T07:00:40-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-announces-general-alignment-fda-pathway-potential-eua 2023-06-26T07:01:25-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-announces-additional-positive-initial-data-ongoing-phase 2023-07-17T07:00:48-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-announces-appointment-sara-cotter-board-directors 2023-07-27T16:01:54-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-host-conference-call-discussing-second-quarter-2023 2023-08-29T18:02:42-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-reports-second-quarter-2023-financial-results-and 2023-08-30T06:58:45-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-appoints-william-duke-chief-financial-officer 2024-01-03T17:13:17-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-participate-upcoming-investor-conferences 2024-01-03T17:11:34-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-announces-dosing-first-participant-canopy-phase-3 2024-01-03T17:08:28-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-participate-upcoming-investor-conferences-0 2024-01-03T17:07:03-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-host-conference-call-discussing-third-quarter-2023 2024-01-03T16:49:19-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-reports-third-quarter-2023-financial-results-and-recent 2024-01-03T16:47:24-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-announces-positive-initial-results-ongoing-canopy-phase 2024-01-03T16:45:26-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-submits-request-emergency-use-authorization-eua-us-fda 2024-01-03T13:26:26-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-participate-guggenheim-healthcare-talks-6th-annual 2024-02-05T16:02:56-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-announces-fda-authorization-emergency-use-pemgardatm 2024-03-22T19:40:03-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-announces-interim-exploratory-data-vyd222-ongoing-canopy 2024-03-22T15:29:03-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-reports-full-year-2023-financial-results-and-recent 2024-03-28T07:00:51-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-provides-pemgardatm-launch-update-and-announces-2024-net 2024-04-04T16:01:36-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-announces-ceo-transition 2024-04-12T07:30:14-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-receives-healthcare-common-procedure-coding-system-hcpcs 2024-04-15T07:30:54-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-announces-20-million-25-million-improvement-projected 2024-04-30T07:30:18-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-host-conference-call-discussing-first-quarter-2024 2024-05-02T17:13:44-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-pursue-rapid-immunobridging-pathway-potential-eua 2024-05-07T07:30:37-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-reports-first-quarter-2024-financial-results-and-recent 2024-05-09T16:01:39-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-participate-hc-wainwright-2nd-annual-bioconnect-investor 2024-05-13T16:01:32-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-elects-two-new-independent-members-its-board-directors 2024-05-22T07:00:57-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-present-data-2024-american-society-clinical-oncology 2024-05-29T07:01:04-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-announces-appointment-timothy-lee-chief-commercial 2024-05-31T07:00:39-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-announces-general-alignment-us-fda-repeatable-expedient 2024-05-31T07:05:34-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-participate-jefferies-global-healthcare-conference 2024-06-03T16:01:18-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-announces-antiviral-activity-vyd222-pemivibart-against 2024-06-14T07:01:19-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-announces-its-addition-russell-2000r-and-russell-3000r 2024-07-01T07:01:38-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-host-conference-call-discussing-second-quarter-2024 2024-08-12T16:01:35-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-reports-second-quarter-2024-financial-results-and-recent 2024-08-14T08:01:34-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-announces-pemgardatm-pemivibart-demonstrated-84-relative 2024-08-27T07:01:30-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-announces-continued-neutralizing-activity-pemgardatm 2024-09-03T07:01:55-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-doses-first-participants-phase-1-clinical-trial-vyd2311 2024-09-04T07:01:50-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-participate-upcoming-investor-conferences-1 2024-09-05T07:01:13-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-ready-upcoming-respiratory-virus-season-pemgardatm 2024-09-12T07:01:11-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-provides-detailed-virology-data-and-analysis-sars-cov-2 2024-09-23T07:01:12-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-announces-us-fda-has-updated-pemgardatm-eua-fact-sheet 2024-10-01T07:01:19-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-present-pemgardatm-pemivibart-data-infectious-disease 2024-10-16T07:01:30-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-phase-3-long-term-exploratory-clinical-efficacy-data 2024-10-29T14:28:44-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-reports-preliminary-third-quarter-2024-results-withdraws 2024-10-29T07:03:52-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-host-third-quarter-2024-financial-results-and-corporate 2024-11-06T07:01:19-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-participate-guggenheim-securities-healthcare-innovation 2024-11-06T08:03:06-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-announces-preprints-conveying-canopy-phase-3-clinical 2024-11-12T08:30:40-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-announces-new-england-journal-medicine-publishes-letter 2024-11-14T07:01:58-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-reports-third-quarter-2024-financial-results-and-recent 2024-11-14T07:05:59-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-announces-continued-neutralizing-activity-pemgardatm-0 2025-01-10T07:01:32-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-provides-another-positive-sars-cov-2-variant-data 2025-01-27T07:01:56-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-announces-preliminary-fourth-quarter-2024-financial 2025-02-03T06:55:54-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-announces-positive-phase-12-clinical-data-vyd2311 2025-02-03T07:00:29-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-announces-partnership-pro-football-coach-jim-harbaugh 2025-02-05T09:31:08-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-present-oppenheimer-35th-annual-healthcare-life-sciences 2025-02-10T07:00:17-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/fda-declined-invivyds-request-expand-existing-emergency-use 2025-02-24T07:05:29-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-announces-continued-neutralizing-activity-pemgardatm-1 2025-03-05T07:05:54-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-reports-fourth-quarter-and-full-year-2024-financial 2025-03-20T08:01:37-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-appoints-ajay-royan-founder-mithril-capital-its-board 2025-03-26T16:16:19-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-announces-30m-non-dilutive-loan-facility-silicon-valley 2025-04-21T07:01:31-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-host-first-quarter-2025-financial-results-and-corporate 2025-05-08T07:01:36-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-announces-new-pipeline-discovery-program-focused 2025-05-12T07:01:15-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-participate-hc-wainwright-3rd-annual-bioconnect-investor 2025-05-13T07:01:35-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-files-citizen-petition-urging-fda-focus-monoclonal 2025-05-14T07:01:39-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-reports-first-quarter-2025-financial-results-and-recent 2025-05-15T07:01:44-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-commends-fda-focus-contemporary-evidence-evaluating 2025-05-21T09:30:46-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-announces-inclusion-pemgardar-pemivibart-national 2025-05-23T07:01:36-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-announces-publication-landmark-canopy-phase-3-pemgardar 2025-05-27T07:01:32-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-announces-positive-full-phase-12-clinical-data-vyd2311 2025-06-26T07:01:57-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-and-leading-researchers-form-spear-spike-protein 2025-07-02T07:01:12-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/national-comprehensive-cancer-networkr-nccnr-guidelines 2025-07-21T07:06:18-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/scientist-dr-akiko-iwasaki-joins-spear-study-group-investigate 2025-07-23T07:01:37-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-aligns-us-fda-rapid-pathway-full-approval-bla-vaccine 2025-08-14T16:47:47-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-reports-second-quarter-2025-financial-results-and-recent 2025-08-14T16:50:12-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-announces-continued-neutralizing-activity-pemgardar 2025-08-18T16:33:59-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-announces-proposed-public-offering-common-stock 2025-08-20T16:01:13-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-announces-pricing-50-million-public-offering-common 2025-08-20T23:59:24-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-announces-closing-575-million-public-offering-and-full 2025-08-22T12:01:22-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-participate-upcoming-investor-conferences-2 2025-08-27T07:02:33-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/spear-study-group-present-its-recommended-long-covid-antibody-0 2025-09-11T09:05:42-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/news-test-release 2025-09-12T11:29:33-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/fdas-makary-covid-shot-guidance-coming-soon 2025-09-12T11:28:53-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/nccn-guidelines-now-recommend-pemivibart-covid-19-prevention-b 2025-09-12T11:28:14-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-claims-pemgarda-mab-follow-could-hold-its-own-against 2025-09-12T11:27:30-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-spear-study-group-launch-long-covid-monoclonal-antibody 2025-09-12T11:26:40-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/race-find-measles-treatment-infections-surge 2025-09-12T11:26:07-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/under-radar-biotech-finds-fda-more-receptive-alternative-covid 2025-09-12T09:07:00-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-announces-appointment-kristie-kuhl-chief-communications 2025-09-17T07:01:56-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-appoints-paul-b-bolno-md-its-board-directors 2025-09-24T16:01:29-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-announces-us-ind-clearance-and-alignment-us-fda-pivotal 2025-10-06T07:01:35-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-host-webcast-revolution-clinical-program-vyd2311-vaccine 2025-10-28T19:31:24-04:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-host-third-quarter-2025-financial-results-and-corporate 2025-11-03T16:02:05-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-reports-third-quarter-2025-financial-results-and-recent 2025-11-06T07:01:53-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-announces-proposed-public-offering-common-stock-0 2025-11-17T16:01:56-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-announces-pricing-125-million-public-offering-common 2025-11-17T22:40:36-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-announces-selection-potential-best-class-rsv-antibody 2025-11-24T07:01:35-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-participate-8th-annual-evercore-healthcare-conference 2025-12-01T16:17:16-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-announces-initiation-declaration-clinical-trial-phase-3 2025-12-23T07:01:31-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-earns-fast-track-designation-vyd2311-vaccine-alternative 2025-12-23T07:05:31-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-reports-preliminary-fourth-quarter-2025-revenue-and 2026-01-08T07:01:10-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-and-spear-study-group-announce-plan-phase-2-study 2026-01-20T07:01:55-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-announces-partnership-world-champion-skier-lindsey-vonn 2026-01-22T07:01:37-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-teams-olympic-skier-lindsey-vonn-antibody-education 2026-02-02T16:43:14-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-aligns-us-fda-liberty-phase-3-trial-evaluate-safety 2026-02-03T07:01:32-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/conversation-marc-elia-dr-michael-mina-monoclonal-antibodies 2026-02-20T16:03:31-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/new-publication-demonstrates-variant-agnostic-correlate 2026-02-24T07:01:56-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-reports-inducement-grants-under-nasdaq-listing-rule 2026-03-02T16:01:35-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-host-fourth-quarter-and-full-year-2025-financial-results 2026-03-02T16:10:36-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-appoints-distinguished-physician-and-scientist-michael 2026-03-05T07:01:33-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-reports-fourth-quarter-and-full-year-2025-financial 2026-03-05T07:03:57-05:00 0.5 https://investors.invivyd.com/news-releases/news-release-details/invivyd-announces-presentation-world-vaccine-congress-washington 2026-03-30T16:06:33-04:00 0.5 https://investors.invivyd.com/sec-filings/sec-filing/d/0001567619-20-019325 2020-11-12T17:25:45-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/d/0001567619-20-019327 2020-11-12T17:29:24-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/d/0001832038-21-000001 2021-04-30T15:15:29-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/s-1/0001193125-21-217506 2021-07-16T16:58:53-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/drsa/0000950123-21-008733 2021-07-17T00:20:16-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/drs/0000950123-21-007258 2021-07-20T00:21:19-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/drsa/0000950123-21-008281 2021-07-20T00:22:04-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/s-1a/0001193125-21-232137 2021-08-02T06:23:05-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-a12b/0001193125-21-233921 2021-08-03T06:16:06-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/s-1a/0001193125-21-236445 2021-08-04T17:32:54-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/3/0001104659-21-101016 2021-08-05T21:15:32-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/3/0001209191-21-050069 2021-08-05T21:26:06-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/3/0001209191-21-050066 2021-08-05T21:26:07-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/3/0001209191-21-050071 2021-08-05T21:26:08-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/3/0001209191-21-050067 2021-08-05T21:26:08-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/3/0001209191-21-050073 2021-08-05T21:26:09-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/s-1mef/0001193125-21-238145 2021-08-05T21:26:09-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/3/0001209191-21-050070 2021-08-05T21:26:09-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/3/0001209191-21-050074 2021-08-05T21:26:09-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/3/0001209191-21-050075 2021-08-05T21:26:10-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/3/0001209191-21-050080 2021-08-05T21:37:14-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/3/0001209191-21-050079 2021-08-05T21:37:15-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/3/0001209191-21-050081 2021-08-05T21:37:16-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/3/0001209191-21-050077 2021-08-05T21:37:18-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/3/0001209191-21-050078 2021-08-05T21:37:20-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/3/0001209191-21-050076 2021-08-05T21:37:20-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/3/0001209191-21-050082 2021-08-05T21:45:44-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/effect/9999999995-21-003063 2021-08-06T06:21:06-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/424b4/0001193125-21-239375 2021-08-06T16:58:07-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0001209191-21-050488 2021-08-09T19:56:11-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0001209191-21-050490 2021-08-09T19:58:55-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0001209191-21-050489 2021-08-09T19:58:55-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0001209191-21-050491 2021-08-09T20:01:09-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0001209191-21-050492 2021-08-09T20:01:44-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-21-242044 2021-08-10T17:29:49-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0001104659-21-104447 2021-08-12T21:04:17-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0001209191-21-051295 2021-08-12T21:25:37-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/3a/0001209191-21-051294 2021-08-12T21:25:39-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0001209191-21-051297 2021-08-12T21:36:16-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0001209191-21-051296 2021-08-12T21:36:16-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0001209191-21-051298 2021-08-12T21:36:26-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0001209191-21-051299 2021-08-12T21:36:26-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/sc-13d/0001193125-21-252773 2021-08-20T16:24:40-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/sc-13d/0001193125-21-252785 2021-08-20T16:30:13-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/s-8/0001193125-21-254034 2021-08-23T16:38:14-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/upload/0000000000-21-009132 2021-09-03T00:05:02-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/upload/0000000000-21-009469 2021-09-03T00:05:10-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/upload/0000000000-21-008441 2021-09-03T00:05:50-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/corresp/0001193125-21-234898 2021-09-03T00:05:52-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/corresp/0001193125-21-234964 2021-09-03T00:05:52-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/corresp/0001193125-21-234913 2021-09-03T00:05:53-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/corresp/0001193125-21-217519 2021-09-03T00:05:57-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/corresp/0001193125-21-232141 2021-09-03T00:06:41-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-21-269490 2021-09-10T07:56:17-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/sc-13g/0000315066-21-001719 2021-09-10T09:35:20-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-21-277284 2021-09-20T16:06:27-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/10-q/0000950170-21-001832 2021-09-20T16:20:19-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-21-286813 2021-09-29T16:43:34-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/sc-13g/0000905718-21-001274 2021-10-05T16:13:25-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-21-301964 2021-10-19T16:04:40-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/3/0001209191-21-062483 2021-11-02T18:02:34-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0001209191-21-062491 2021-11-02T18:04:44-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/3a/0001209191-21-062724 2021-11-03T16:49:50-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-21-328992 2021-11-15T08:09:37-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/10-q/0000950170-21-004586 2021-11-15T16:26:35-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-21-331387 2021-11-16T17:25:41-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-21-336946 2021-11-22T17:07:55-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/3/0001209191-21-066195 2021-11-22T18:36:21-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/3/0001209191-21-066196 2021-11-22T18:37:32-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0001209191-21-066581 2021-11-23T18:10:58-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0001209191-21-066591 2021-11-23T18:14:55-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-21-341832 2021-11-29T08:25:40-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-21-356251 2021-12-14T09:12:06-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-22-008197 2022-01-13T08:03:33-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0001209191-22-006011 2022-02-01T18:11:58-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0001209191-22-006015 2022-02-01T18:13:12-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0001209191-22-006020 2022-02-01T18:14:54-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0001209191-22-006022 2022-02-01T18:16:33-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0001209191-22-006024 2022-02-01T18:17:08-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0001209191-22-006027 2022-02-01T18:19:49-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0001209191-22-006030 2022-02-01T18:19:49-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/sc-13ga/0000315066-22-000818 2022-02-09T09:12:44-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/sc-13ga/0000905718-22-000207 2022-02-11T16:03:04-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/sc-13g/0001193125-22-040725 2022-02-14T12:32:37-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-22-046765 2022-02-18T17:32:16-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-22-047719 2022-02-22T07:59:30-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-22-050174 2022-02-23T17:13:02-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-22-061608 2022-03-01T17:37:17-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/upload/0000000000-21-007445 2022-03-08T22:32:46-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-ka/0001193125-22-079997 2022-03-21T06:32:24-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-22-080001 2022-03-21T06:34:07-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/sc-13da/0001193125-22-088618 2022-03-30T07:52:43-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/sc-13da/0001193125-22-088640 2022-03-30T07:53:40-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-22-088649 2022-03-30T07:56:13-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/sc-13d/0001193125-22-089834 2022-03-30T16:24:17-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/3/0000899243-22-012829 2022-03-30T18:21:12-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000899243-22-012830 2022-03-30T18:21:14-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000899243-22-012866 2022-03-30T21:14:28-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000899243-22-012864 2022-03-30T21:14:32-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/3/0001567619-22-007730 2022-03-30T21:57:51-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/3/0001567619-22-007732 2022-03-30T22:07:35-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/10-k/0000950170-22-005112 2022-03-31T08:21:47-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/sc-13d/0000902664-22-002385 2022-04-01T06:23:02-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000899243-22-013098 2022-04-01T16:12:32-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/3/0000902664-22-002394 2022-04-01T16:17:09-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/3a/0001567619-22-008202 2022-04-06T17:04:21-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/sc-13d/0000914121-22-002824 2022-04-07T06:11:47-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/prec14a/0001193125-22-100921 2022-04-11T06:46:02-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/prrn14a/0001193125-22-117915 2022-04-25T17:24:51-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/sc-13da/0001193125-22-118250 2022-04-26T06:09:11-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/sc-13da/0000914121-22-003216 2022-04-26T06:13:41-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/sc-13da/0001193125-22-118329 2022-04-26T06:16:04-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/sc-13da/0001193125-22-118343 2022-04-26T06:16:28-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/prec14a/0001193125-22-118162 2022-04-26T08:50:31-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/sc-13da/0000902664-22-002675 2022-04-26T11:47:03-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/prrn14a/0001193125-22-122799 2022-04-27T13:16:01-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/defc14a/0001193125-22-133527 2022-04-29T16:05:05-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/10-ka/0001193125-22-134035 2022-04-29T17:26:18-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-22-149345 2022-05-13T07:02:29-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/10-q/0000950170-22-009799 2022-05-13T08:04:40-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/s-8/0001193125-22-149581 2022-05-13T10:27:08-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/prec14c/0001193125-22-155139 2022-05-19T17:07:39-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-22-155156 2022-05-19T17:16:57-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/defa14c/0001193125-22-155177 2022-05-19T17:24:57-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/prer14c/0001193125-22-164089 2022-05-31T17:13:48-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/defc14c/0001193125-22-166247 2022-06-02T16:25:47-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/dfan14a/0001193125-22-167561 2022-06-06T06:08:46-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-22-177777 2022-06-21T17:19:07-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/defa14c/0001193125-22-177782 2022-06-21T17:21:53-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-22-178882 2022-06-22T17:19:36-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/sc-13da/0000902664-22-003399 2022-06-24T16:16:51-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000899243-22-023969 2022-06-24T16:31:01-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000899243-22-023996 2022-06-24T16:35:38-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000899243-22-023984 2022-06-24T16:35:42-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000899243-22-024012 2022-06-24T16:38:21-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000899243-22-024015 2022-06-24T16:38:22-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/3/0000899243-22-024018 2022-06-24T16:40:01-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000899243-22-024021 2022-06-24T16:42:02-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000899243-22-024027 2022-06-24T16:47:44-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/sc-13da/0001193125-22-181596 2022-06-24T16:49:11-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/sc-13da/0001193125-22-181609 2022-06-24T16:56:08-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000899243-22-024047 2022-06-24T17:04:42-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/sc-13da/0000914121-22-004040 2022-06-24T17:08:41-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/sc-13da/0001193125-22-181642 2022-06-24T17:12:29-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-22-186218 2022-06-30T16:33:02-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/sc-13da/0001193125-22-187564 2022-07-05T08:12:39-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-22-187977 2022-07-05T16:43:06-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000899243-22-025328 2022-07-06T16:08:32-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-22-220559 2022-08-15T07:28:44-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/10-q/0000950170-22-017242 2022-08-15T08:10:55-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000899243-22-029295 2022-08-19T17:01:48-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/sc-13da/0000902664-22-004064 2022-08-19T17:25:07-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000899243-22-030183 2022-09-01T16:31:16-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-22-242433 2022-09-12T07:48:55-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-22-243285 2022-09-13T07:33:08-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/s-3/0001193125-22-253372 2022-09-28T17:10:21-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/effect/9999999995-22-002946 2022-10-06T06:08:37-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-22-262167 2022-10-13T16:18:46-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/3/0000899243-22-033561 2022-10-13T16:56:05-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-22-267606 2022-10-24T16:32:32-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/3/0000899243-22-034028 2022-10-24T16:52:54-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000899243-22-034029 2022-10-24T16:55:13-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/corresp/0001193125-22-256380 2022-11-04T00:09:09-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000899243-22-035198 2022-11-04T16:15:27-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/upload/0000000000-22-005843 2022-11-07T01:30:33-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/corresp/0001193125-22-164093 2022-11-07T01:30:51-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/upload/0000000000-22-004153 2022-11-07T01:31:15-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/upload/0000000000-22-010798 2022-11-07T01:33:01-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-22-282613 2022-11-10T16:23:26-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/10-q/0000950170-22-024516 2022-11-10T16:39:52-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-22-287208 2022-11-17T07:12:25-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/d/0001567619-22-021016 2022-11-29T17:18:03-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-22-299428 2022-12-06T16:31:18-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/3/0000899243-22-037803 2022-12-06T17:54:33-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000899243-22-037804 2022-12-06T18:00:55-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000899243-22-038843 2022-12-16T17:13:22-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/3/0000899243-22-038844 2022-12-16T17:13:23-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000899243-22-038845 2022-12-16T17:14:04-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000899243-22-038849 2022-12-16T17:17:10-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000899243-22-038851 2022-12-16T17:19:10-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000899243-22-038853 2022-12-16T17:23:10-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-23-004133 2023-01-09T07:13:41-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/sc-13ga/0000315066-23-001757 2023-02-09T11:52:56-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-23-060699 2023-03-06T07:45:39-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-23-077876 2023-03-23T16:28:26-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/10-k/0000950170-23-009516 2023-03-23T17:11:29-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/3/0000899243-23-009795 2023-03-28T16:57:13-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000899243-23-009798 2023-03-28T17:03:07-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/pre-14a/0001193125-23-088183 2023-03-31T16:38:28-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/def-14a/0001193125-23-096524 2023-04-10T16:09:48-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/defa14a/0001193125-23-096532 2023-04-10T16:12:30-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/ars/0000950170-23-012300 2023-04-10T16:21:34-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/3/0000899243-23-011195 2023-04-12T16:49:48-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000899243-23-011197 2023-04-12T16:52:44-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-23-131287 2023-05-02T07:45:42-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-23-142010 2023-05-11T16:16:05-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/10-q/0000950170-23-021235 2023-05-11T16:17:24-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-23-154233 2023-05-25T16:24:09-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000899243-23-013913 2023-05-25T18:40:49-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000899243-23-013912 2023-05-25T18:40:58-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000899243-23-013916 2023-05-25T18:44:59-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000899243-23-013917 2023-05-25T18:46:12-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000899243-23-013918 2023-05-25T18:46:15-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000899243-23-013920 2023-05-25T18:52:22-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000899243-23-013935 2023-05-25T20:55:33-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-23-177996 2023-06-29T07:11:00-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-23-196086 2023-07-27T16:08:00-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/3/0000950170-23-035177 2023-07-27T16:31:29-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000950170-23-035191 2023-07-27T16:37:43-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-23-209020 2023-08-10T16:07:33-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/10-q/0000950170-23-041352 2023-08-10T16:20:19-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-23-228074 2023-09-05T07:08:39-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/3/0000950170-23-046412 2023-09-05T16:33:02-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000950170-23-046430 2023-09-05T16:38:05-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-23-231961 2023-09-11T07:12:17-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/sc-13ga/0000315066-23-002573 2023-09-11T08:25:54-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-23-274506 2023-11-09T16:15:48-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/10-q/0000950170-23-062043 2023-11-09T16:17:08-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000950170-23-065108 2023-11-20T16:24:56-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-23-297099 2023-12-18T07:20:28-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000950170-23-071905 2023-12-20T16:42:55-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000950170-23-071909 2023-12-20T16:43:03-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000950170-23-071907 2023-12-20T16:43:46-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000950170-23-071915 2023-12-20T16:48:12-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000950170-23-071914 2023-12-20T16:50:57-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000950170-23-071918 2023-12-20T16:55:50-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000950170-23-071919 2023-12-20T16:57:16-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/424b5/0001193125-23-302190 2023-12-22T16:52:54-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-23-302195 2023-12-22T16:55:32-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-24-001013 2024-01-03T07:11:29-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-24-003875 2024-01-08T07:14:52-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/144/0001950047-24-000381 2024-01-19T16:26:51-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/sc-13da/0001193125-24-012170 2024-01-22T16:21:07-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000950170-24-006070 2024-01-22T16:22:05-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/3/0000950170-24-007972 2024-01-26T16:33:54-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000950170-24-007981 2024-01-26T16:39:42-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/sc-13ga/0000315066-24-001257 2024-02-09T09:17:35-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0000950170-24-013243 2024-02-09T16:03:56-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/s-3/0001193125-24-030154 2024-02-09T16:49:18-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/sc-13g/0001172661-24-000706 2024-02-12T16:08:09-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/sc-13g/0001193125-24-036575 2024-02-14T17:14:34-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-24-075582 2024-03-25T06:06:54-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-24-079597 2024-03-28T07:06:54-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/10-k/0000950170-24-037610 2024-03-28T07:18:39-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-24-087408 2024-04-04T17:27:46-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-24-093929 2024-04-12T07:38:17-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/def-14a/0000950170-24-045549 2024-04-18T16:09:18-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/ars/0000950170-24-045570 2024-04-18T16:18:37-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/effect/9999999995-24-001044 2024-04-22T06:09:28-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-24-132585 2024-05-07T07:43:48-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-24-135260 2024-05-09T16:11:34-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/10-q/0000950170-24-057017 2024-05-09T16:23:16-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/s-8/0000950170-24-057117 2024-05-09T16:34:33-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/144/0001950047-24-003783 2024-05-16T16:12:11-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/upload/0000000000-24-002075 2024-05-18T00:13:49-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/corresp/0000950170-24-045558 2024-05-18T00:13:50-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0000950170-24-063279 2024-05-22T07:12:30-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/3/0000950170-24-064003 2024-05-23T16:57:07-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000950170-24-064007 2024-05-23T16:59:38-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/3/0000950170-24-064026 2024-05-23T17:10:57-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000950170-24-064071 2024-05-23T17:42:28-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000950170-24-064113 2024-05-23T18:15:45-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000950170-24-064126 2024-05-23T18:26:08-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000950170-24-064138 2024-05-23T18:32:36-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000950170-24-064146 2024-05-23T18:32:44-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000950170-24-064152 2024-05-23T18:34:39-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/144/0001963745-24-000026 2024-05-29T17:32:47-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-24-151007 2024-05-31T07:14:55-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000950170-24-067438 2024-05-31T17:11:25-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/3/0000950170-24-069959 2024-06-06T17:00:19-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000950170-24-069965 2024-06-06T17:03:05-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0000950170-24-073322 2024-06-14T07:11:07-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-24-200256 2024-08-14T08:23:28-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/10-q/0000950170-24-096674 2024-08-14T08:29:35-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-24-207466 2024-08-27T08:07:58-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0000950170-24-102552 2024-09-03T07:08:46-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0000950170-24-103100 2024-09-04T07:12:57-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-24-214779 2024-09-06T09:08:56-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0000950170-24-108624 2024-09-23T07:14:23-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0000950170-24-117934 2024-10-29T07:21:54-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/sc-13ga/0001104659-24-115886 2024-11-08T16:28:01-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/sc-13ga/0000315066-24-002844 2024-11-12T10:38:41-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-24-257993 2024-11-14T07:22:31-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/10-q/0000950170-24-126735 2024-11-14T07:29:36-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/sc-13ga/0001172661-24-004731 2024-11-14T09:19:32-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/sc-13ga/0001193125-24-258666 2024-11-14T16:36:51-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0000950170-24-132158 2024-12-02T15:17:51-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/144/0001950047-24-009555 2024-12-09T16:30:22-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000950170-24-135509 2024-12-11T18:29:17-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/sc-13da/0001193125-24-277124 2024-12-12T16:41:21-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000950170-24-136858 2024-12-16T20:38:13-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000950170-24-138597 2024-12-19T17:57:58-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/144/0001950047-24-010012 2024-12-20T16:49:48-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000950170-24-140613 2024-12-26T19:56:18-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0000950170-24-140800 2024-12-27T16:17:51-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000950170-24-141701 2024-12-31T19:25:14-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0000950170-25-003781 2025-01-10T07:09:51-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0000950170-25-008995 2025-01-27T07:08:34-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0000950170-25-012018 2025-02-03T07:08:01-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/0000315066-25-000768 2025-02-12T09:21:18-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000950170-25-023238 2025-02-19T16:33:14-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000950170-25-023241 2025-02-19T16:33:15-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000950170-25-023232 2025-02-19T16:33:54-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000950170-25-023245 2025-02-19T16:33:59-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000950170-25-023239 2025-02-19T16:34:00-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0000950170-25-025227 2025-02-24T07:15:21-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0000950170-25-033068 2025-03-05T07:15:21-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0000950170-25-042331 2025-03-20T08:07:58-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/10-k/0000950170-25-042332 2025-03-20T08:15:48-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0000950170-25-045302 2025-03-26T16:32:40-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/3/0000950170-25-045455 2025-03-26T17:27:48-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000950170-25-045465 2025-03-26T17:32:26-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/def-14a/0000950170-25-051587 2025-04-07T16:11:56-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/defa14a/0000950170-25-051610 2025-04-07T16:23:56-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/ars/0000950170-25-051619 2025-04-07T16:30:48-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0000950170-25-056005 2025-04-21T07:14:34-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0000950170-25-058705 2025-04-25T16:08:45-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0000950170-25-068543 2025-05-12T07:10:39-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-25-120261 2025-05-15T07:13:56-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/10-q/0000950170-25-071974 2025-05-15T07:19:35-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/schedule-13ga/0001172661-25-001965 2025-05-15T08:44:39-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0000950170-25-075199 2025-05-20T16:20:39-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000950170-25-076305 2025-05-22T16:08:58-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000950170-25-076316 2025-05-22T16:11:34-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000950170-25-076323 2025-05-22T16:13:31-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000950170-25-076332 2025-05-22T16:15:39-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000950170-25-076337 2025-05-22T16:17:43-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000950170-25-076343 2025-05-22T16:17:52-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0000950170-25-090172 2025-06-26T07:14:23-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0000950170-25-092528 2025-07-02T07:12:00-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/schedule-13ga/0001641172-25-023725 2025-08-14T08:03:04-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-25-180890 2025-08-14T16:58:41-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/10-q/0000950170-25-109029 2025-08-14T17:02:52-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/144/0001123292-25-000368 2025-08-18T18:49:55-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/144/0001123292-25-000370 2025-08-18T18:54:11-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/144/0001123292-25-000372 2025-08-18T18:55:29-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/144/0001123292-25-000374 2025-08-18T18:56:51-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/144/0001123292-25-000376 2025-08-18T18:56:51-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000950170-25-110339 2025-08-19T21:25:38-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000950170-25-110341 2025-08-19T21:25:45-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000950170-25-110346 2025-08-19T21:34:46-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000950170-25-110343 2025-08-19T21:34:46-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0000950170-25-110344 2025-08-19T21:34:54-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/424b5/0001193125-25-184075 2025-08-20T16:08:10-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/fwp/0001193125-25-184081 2025-08-20T16:11:22-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/424b5/0001193125-25-185639 2025-08-22T06:09:21-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0000950170-25-110952 2025-08-22T16:09:31-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/schedule-13da/0000902664-25-003854 2025-08-26T16:16:09-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/schedule-13g/0000902664-25-003863 2025-08-27T16:19:47-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/schedule-13g/0001415889-25-023305 2025-08-29T16:35:42-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/schedule-13g/0001274173-25-000255 2025-09-08T13:09:50-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-25-215541 2025-09-24T16:49:07-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/3/0001193125-25-215619 2025-09-24T17:08:07-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0001193125-25-215634 2025-09-24T17:10:59-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/s-3/0001193125-25-228321 2025-10-02T16:12:43-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-25-230898 2025-10-06T07:11:34-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/schedule-13g/0001213900-25-098418 2025-10-14T09:08:16-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/schedule-13g/0000921895-25-002791 2025-10-22T20:13:20-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-25-258526 2025-10-30T16:12:25-04:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-25-268057 2025-11-06T07:14:55-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/10-q/0001193125-25-268076 2025-11-06T07:20:13-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/schedule-13da/0001193125-25-272648 2025-11-07T17:53:49-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/schedule-13da/0001193125-25-277894 2025-11-12T17:04:48-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/schedule-13ga/0001172661-25-004828 2025-11-14T08:18:19-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/schedule-13ga/0001274173-25-000285 2025-11-14T11:56:38-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/schedule-13ga/0000902664-25-004982 2025-11-14T16:04:36-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/424b5/0001193125-25-284616 2025-11-17T16:09:08-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/144/0001950047-25-008974 2025-11-17T16:37:01-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/fwp/0001193125-25-284712 2025-11-17T16:41:48-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/424b5/0001193125-25-286661 2025-11-19T06:05:43-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/schedule-13da/0001193125-25-288171 2025-11-19T16:33:09-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-25-288347 2025-11-19T17:27:34-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0001193125-25-289825 2025-11-20T16:23:33-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-25-291992 2025-11-24T11:21:29-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/schedule-13g/0001193125-25-297003 2025-11-25T16:03:53-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/s-3a/0001193125-25-327055 2025-12-19T17:08:59-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-25-329488 2025-12-23T07:11:35-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/144/0001950047-25-010678 2025-12-23T16:25:08-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/effect/9999999995-25-003900 2025-12-29T06:06:29-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/schedule-13da/0001193125-25-335350 2025-12-29T16:16:33-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-26-006997 2026-01-08T07:13:14-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0001193125-26-031822 2026-01-30T16:20:37-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0001193125-26-031819 2026-01-30T16:20:37-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0001193125-26-031840 2026-01-30T16:22:29-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0001193125-26-031856 2026-01-30T16:22:38-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0001193125-26-031858 2026-01-30T16:26:29-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/schedule-13ga/0001213900-26-015651 2026-02-12T17:02:47-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/schedule-13ga/0001012975-26-000135 2026-02-13T16:11:08-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/schedule-13ga/0000921895-26-000469 2026-02-17T16:20:51-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/schedule-13ga/0000902664-26-001128 2026-02-17T16:33:18-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/schedule-13ga/0001346824-26-000045 2026-02-17T16:38:34-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/144/0001193125-26-055348 2026-02-17T18:28:22-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/144/0001193125-26-055356 2026-02-17T18:31:40-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/144/0001193125-26-055365 2026-02-17T18:34:47-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/144/0001193125-26-055370 2026-02-17T18:37:51-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/144/0001193125-26-055377 2026-02-17T18:41:57-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0001193125-26-057815 2026-02-18T20:50:17-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0001193125-26-057814 2026-02-18T20:50:26-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0001193125-26-057819 2026-02-18T20:53:02-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0001193125-26-057822 2026-02-18T20:53:02-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/4/0001193125-26-057828 2026-02-18T20:59:18-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/8-k/0001193125-26-092528 2026-03-05T07:13:24-05:00 0.4 https://investors.invivyd.com/sec-filings/sec-filing/10-k/0001193125-26-092547 2026-03-05T07:25:29-05:00 0.4 https://investors.invivyd.com/board-member/rene-russo-pharmd 2021-08-02T13:44:43-04:00 0.5 https://investors.invivyd.com/board-member/tillman-gerngross-phd 2021-08-02T13:45:20-04:00 0.5 https://investors.invivyd.com/board-member/terry-mcguire 2021-08-02T13:46:00-04:00 0.5 https://investors.invivyd.com/board-member/ajay-royan 2021-08-02T13:46:25-04:00 0.5 https://investors.invivyd.com/board-member/tom-heyman 2021-08-02T13:46:51-04:00 0.5 https://investors.invivyd.com/board-member/howard-mayer-md 2021-08-02T13:47:21-04:00 0.5 https://investors.invivyd.com/board-member/anand-shah-md 2021-08-02T13:47:52-04:00 0.5 https://investors.invivyd.com/board-member/michael-wyzga 2021-08-02T13:48:20-04:00 0.5 https://investors.invivyd.com/board-member/ellen-marram-mba 2021-12-01T08:48:38-05:00 0.5 https://investors.invivyd.com/board-member/redonda-miller-md-mba 2021-12-01T08:49:28-05:00 0.5 https://investors.invivyd.com/board-member/marc-elia 2022-06-23T12:08:42-04:00 0.5 https://investors.invivyd.com/board-member/tamsin-berry 2022-06-24T12:19:49-04:00 0.5 https://investors.invivyd.com/board-member/clive-meanwell-md 2022-07-01T11:00:03-04:00 0.5 https://investors.invivyd.com/analyst/patrick-trucchio-cfa 2023-05-01T14:43:12-04:00 0.5 https://investors.invivyd.com/board-member/kevin-mclaughlin 2024-05-22T07:00:00-04:00 0.5 https://investors.invivyd.com/board-member/srishti-gupta-md 2024-05-22T07:00:00-04:00 0.5 https://investors.invivyd.com/board-member/sara-cotter 2024-05-22T07:00:00-04:00 0.5 https://investors.invivyd.com/analyst/jason-kolbert 2024-11-14T14:28:45-05:00 0.5 https://investors.invivyd.com/board-member/paul-b-bolno-md 2025-09-26T10:10:46-04:00 0.5 https://investors.invivyd.com/analyst/josh-schimmer 2025-10-31T15:49:55-04:00 0.5 https://investors.invivyd.com/analyst/thomas-shrader 2025-12-22T08:51:19-05:00 0.5